CapsoVision, Inc (CV) stock
CVNasdaqElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 7/30733% above fair value
$6.65+0.18 (+2.78%)
Close on Nov 17, 2026Market cap $332.81MP/E –Yield –
CapsoVision operating income
Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.
CapsoVision's operating income for the twelve months ending Jun 30, 2026 was -$30.16M. For fiscal 2025 it was -$25.52M.
Annual operating income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$25.52M | – |
| FY2024 | Dec 31, 2024 | -$19.92M | – |
Quarterly operating income
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$7.58M | – |
| Q1 FY2026 | Mar 31, 2026 | -$7.09M | – |
| Q4 FY2025 | Dec 31, 2025 | -$7.46M | – |
| Q3 FY2025 | Sep 30, 2025 | -$8.02M | – |
| Q2 FY2025 | Jun 30, 2025 | -$4.65M | – |
| Q1 FY2025 | Mar 31, 2025 | -$5.38M | – |
| Q4 FY2024 | Dec 31, 2024 | -$4.63M | – |
| Q3 FY2024 | Sep 30, 2024 | -$5.80M | – |
| Q2 FY2024 | Jun 30, 2024 | -$5.27M | – |
See a number that looks wrong?